Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

SARS-CoV-2 responsive T cell numbers are associated with protection from COVID-19: A prospective cohort study in keyworkers

David Wyllie, Ranya Mulchandani, Hayley E Jones, Sian Taylor-Phillips, Tim Brooks, Andre Charlett, Anthony E Ades, EDSAB-HOME investigators, Andrew Makin, Isabel Oliver, Philippa Moore, John Boyes, Anil Hormis, Neil Todd, Ian Reckless
doi: https://doi.org/10.1101/2020.11.02.20222778
David Wyllie
1Public Health England
Roles: Consultant Microbiologist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: david.wyllie{at}phe.gov.uk
Ranya Mulchandani
1Public Health England
Roles: Field Epidemiology Training Programme (UK-FETP) Fellow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hayley E Jones
2University of Bristol
Roles: Senior Lecturer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sian Taylor-Phillips
3University of Warwick
Roles: Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tim Brooks
1Public Health England
Roles: Consultant Microbiologist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andre Charlett
1Public Health England
Roles: Head of Statistics and Modelling
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony E Ades
2University of Bristol
Roles: Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Makin
4Oxford Immunotec Ltd
Roles: Vice President, Medical Affairs
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabel Oliver
1Public Health England
Roles: Director, National Infection Service
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philippa Moore
5Gloucestershire Hospitals, NHS Foundation Trust, Gloucester, UK
Roles: Consultant Microbiologist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Boyes
5Gloucestershire Hospitals, NHS Foundation Trust, Gloucester, UK
Roles: Consultant Microbiologist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anil Hormis
6The Rotherham NHS Foundation Trust, Rotherham, UK
Roles: Consultant Anaesthetist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neil Todd
7York Teaching Hospital NHS Foundation Trust, York, UK
Roles: Consultant Microbiologist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian Reckless
8Milton Keynes University, Hospital NHS Foundation Trust, Milton Keynes, UK
Roles: Consultant Physician
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Immune correlates of protection from COVID-19 are important, but incompletely understood.

Methods We conducted a prospective cohort study in 2,826 participants working in hospitals and Fire and Police services in England, UK during the pandemic(ISRCTN5660922). Of these, 2,672 were unselected volunteers recruited irrespective of previous SARS-CoV-2 RT-PCR test results, and 154 others were recruited separately specifically because they previously tested positive. At recruitment in June 2020, we measured numbers of interferon-γ secreting, SARS-CoV-2 responsive T cells using T-SPOT® Discovery SARS-CoV-2 kits (Oxford Immunotec Ltd), and antibodies to SARS-CoV-2 proteins using commercial immunoassays. We then described time to microbiologically confirmed SARS-CoV-2 infection, stratified by immunological parameters.

Results T cells responsive to the spike (S), nuclear (N) and membrane proteins (M) dominated the responses measured. Using the sum of the spots (responsive cells within each well of 250,000 peripheral blood mononuclear cells) for S, N and M antigens minus the control, the 2,672 unselected participants were divided into those with higher responses (n=669, 25.4%; median 30 spots (IQR 18,54)) and those with low responses (n=2016, 76.7%, median 3 (IQR 1,6)), the cutoff we derived being 12 spots. Of the participants with higher T cell responses, 367 (53%) had detectable antibodies against the N or S proteins. During a median of 118 days follow-up, 20 participants with lower T cell responses developed COVID-19, compared with none in the population with high T cell responses (log-rank test, p=6×10−3).

Conclusions Peripheral blood SARS-CoV-2 responsive T cell numbers are associated with risk of developing COVID-19.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The study was commissioned by the UK Government Department of Health and Social Care. It was funded and implemented by Public Health England, supported by the NIHR Clinical Research Network (CRN) Portfolio. Oxford Immunotec Ltd did T-SPOT tests at their own cost as part of the study. Department of Health and Social had no role in the study design, data collection, analysis, interpretation of results, writing of the manuscript, or the decision to publish. DW acknowledges support from the NIHR Health Protection Research Unit in Genomics and Data Enabling at the University of Warwick. HEJ, AEA, MH and IO acknowledge support from the NIHR Health Protection Research Unit in Behavioural Science and Evaluation at University of Bristol. STP is supported by an NIHR Career Development Fellowship (CDF-2016-09-018). The views expressed are those of the author(s) and not necessarily those of the NHS, NIHR or the Department of Health and Social Care.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

EDSAB-HOME study was approved by NHS Research Ethics Committee (Health Research Authority, IRAS 284980) on 02-Jun-2020 and PHE Research Ethics and Governance Group (REGG, NR0198) on 21-May-2020. All participants gave written informed consent.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data available on reasonable request to corresponding author.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted November 04, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
SARS-CoV-2 responsive T cell numbers are associated with protection from COVID-19: A prospective cohort study in keyworkers
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
SARS-CoV-2 responsive T cell numbers are associated with protection from COVID-19: A prospective cohort study in keyworkers
David Wyllie, Ranya Mulchandani, Hayley E Jones, Sian Taylor-Phillips, Tim Brooks, Andre Charlett, Anthony E Ades, EDSAB-HOME investigators, Andrew Makin, Isabel Oliver, Philippa Moore, John Boyes, Anil Hormis, Neil Todd, Ian Reckless
medRxiv 2020.11.02.20222778; doi: https://doi.org/10.1101/2020.11.02.20222778
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
SARS-CoV-2 responsive T cell numbers are associated with protection from COVID-19: A prospective cohort study in keyworkers
David Wyllie, Ranya Mulchandani, Hayley E Jones, Sian Taylor-Phillips, Tim Brooks, Andre Charlett, Anthony E Ades, EDSAB-HOME investigators, Andrew Makin, Isabel Oliver, Philippa Moore, John Boyes, Anil Hormis, Neil Todd, Ian Reckless
medRxiv 2020.11.02.20222778; doi: https://doi.org/10.1101/2020.11.02.20222778

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3293)
  • Dentistry and Oral Medicine (364)
  • Dermatology (279)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1171)
  • Epidemiology (13375)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5153)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3268)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1190)
  • Hematology (431)
  • HIV/AIDS (1017)
  • Infectious Diseases (except HIV/AIDS) (14627)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (477)
  • Medical Ethics (127)
  • Nephrology (523)
  • Neurology (4925)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (883)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (724)
  • Orthopedics (281)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (550)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4212)
  • Public and Global Health (7504)
  • Radiology and Imaging (1705)
  • Rehabilitation Medicine and Physical Therapy (1013)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (497)
  • Sports Medicine (424)
  • Surgery (548)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)